18Q21 REARRANGEMENT IN DIFFUSE LARGE CELL LYMPHOMA - INCIDENCE AND CLINICAL-SIGNIFICANCE

被引：91
|
作者：
OFFIT, K
KODURU, PRK
HOLLIS, R
FILIPPA, D
JHANWAR, SC
CLARKSON, BC
CHAGANTI, RSK
机构：
[1] MEM SLOAN KETTERING CANC CTR,HEMATOL & LYMPHOMA SERV,NEW YORK,NY 10021
[2] MEM SLOAN KETTERING CANC CTR,DEPT PATHOL,CANC GENET & CYTOGENET LAB,NEW YORK,NY 10021
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1989年 / 72卷 / 02期
关键词：
D O I：
10.1111/j.1365-2141.1989.tb07680.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：178 / 183
页数：6
相关论文
共 50 条
  • [1] CLINICAL-SIGNIFICANCE OF MORPHOLOGICAL SUBDIVISION IN DIFFUSE LARGE CELL LYMPHOMA
    KWAK, LW
    WILSON, M
    WEISS, LM
    HORNING, SJ
    WARNKE, RA
    DORFMAN, RF
    CANCER, 1991, 68 (09) : 1988 - 1993
  • [2] The 3q27 and 18q21 Translocations for Follicular Lymphoma and Diffuse Large B-Cell Lymphoma in the Rituximab Era
    Watanabe, Reina
    Tomita, Naoto
    Matsumoto, Chihiro
    Hattori, Yukako
    Matsuura, Shiro
    Takasaki, Hirotaka
    Hashimoto, Chizuko
    Fujita, Hiroyuki
    Fujisawa, Shin
    Ishigatsubo, Yoshiaki
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2013, 53 (02) : 107 - 114
  • [3] CLINICAL-SIGNIFICANCE OF HISTOLOGY AND IMMUNOPHENOTYPE IN CHILDHOOD DIFFUSE LARGE CELL LYMPHOMA
    HUTCHISON, RE
    FAIRCLOUGH, DL
    HOLT, H
    PUI, CH
    SANDLUND, JT
    BERARD, CW
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1991, 95 (06) : 787 - 793
  • [4] PROGNOSTIC VALUE OF THE 3Q27 AND 18Q21 TRANSLOCATIONS FOR DIFFUSE LARGE B-CELL LYMPHOMA AND FOLLICULAR LYMPHOMA IN THE RITUXIMAB ERA
    Watanabe, R.
    Tomita, N.
    Matsumoto, C.
    Hattori, Y.
    Matsuura, S.
    Takasaki, H.
    Hashimoto, C.
    Fujita, H.
    Fujisawa, S.
    Ishigatsubo, Y.
    ANNALS OF ONCOLOGY, 2011, 22 : 150 - 150
  • [5] Prognostic value of the 3q27 and 18q21 translocations for diffuse large B-cell lymphoma and follicular lymphoma in the rituximab era
    Watanabe, R.
    Tomita, N.
    Matsumoto, C.
    Hattori, Y.
    Matsuura, S.
    Takasaki, H.
    Hashimoto, C.
    Fujita, H.
    Fujisawa, S.
    Ishigatsubo, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] Clinical Significance of CMYC Rearrangement in Diffuse Large B-Cell Lymphoma
    Caponetti, G. C.
    Dave, B.
    Smith, L.
    Meyer, P.
    Bast, M.
    Bierman, P.
    Bociek, G.
    Vose, J.
    Armitage, J. O.
    Aoun, P.
    Fu, K.
    Greiner, T.
    Chan, W. C.
    Weisenburger, D.
    LABORATORY INVESTIGATION, 2011, 91 : 288A - 288A
  • [7] Clinical Significance of CMYC Rearrangement in Diffuse Large B-Cell Lymphoma.
    Caponetti, G. C.
    Dave, B.
    Smith, L.
    Meyer, P.
    Bast, M.
    Bierman, P.
    Bociek, G.
    Vose, J.
    Armitage, J. O.
    Aoun, P.
    Fu, K.
    Greiner, T.
    Chan, W. C.
    Weisenburger, D.
    MODERN PATHOLOGY, 2011, 24 : 288A - 288A
  • [8] Clinical significance of the t(14;18)(q32;q21) in follicular large cell lymphoma (FLCL)
    Weisenburger, DD
    Gascoyne, RD
    Bierman, PJ
    Shenkier, T
    Horsman, D
    Anderson, JR
    Chan, WC
    Greiner, TC
    Conners, JM
    Vose, JM
    Armitage, JO
    Sanger, WS
    LABORATORY INVESTIGATION, 1996, 74 (01) : 732 - 732
  • [9] CD47 overexpression is common in intestinal non-GCB type diffuse large B-cell lymphoma and associated with 18q21 gain
    Cho, Junhun
    Yoon, Sang Eun
    Kim, Seok Jin
    Ko, Young Hyeh
    Kim, Won Seog
    BLOOD ADVANCES, 2022, 6 (24) : 6120 - 6130
  • [10] Bcl-6 and bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: Correlation with 3q27 and 18q21 chromosomal abnormalities
    Skinnider, BF
    Horsman, DE
    Dupuis, B
    Gascoyne, RD
    HUMAN PATHOLOGY, 1999, 30 (07) : 803 - 808
12345